Goldman Sachs’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.09M | Sell |
724,582
-16,747
| -2% | -$71.3K | ﹤0.01% | 3151 |
|
|
2025
Q1 | $2.79M | Buy |
741,329
+358,412
| +94% | +$1.35M | ﹤0.01% | 3143 |
|
|
2024
Q4 | $2.23M | Sell |
382,917
-79,430
| -17% | -$463K | ﹤0.01% | 3397 |
|
|
2024
Q3 | $5.52M | Buy |
462,347
+61,242
| +15% | +$731K | ﹤0.01% | 2682 |
|
|
2024
Q2 | $4.34M | Sell |
401,105
-35,926
| -8% | -$389K | ﹤0.01% | 2712 |
|
|
2024
Q1 | $4.95M | Buy |
437,031
+121,553
| +39% | +$1.38M | ﹤0.01% | 2574 |
|
|
2023
Q4 | $4.43M | Buy |
315,478
+221,543
| +236% | +$3.11M | ﹤0.01% | 2686 |
|
|
2023
Q3 | $1.16M | Buy |
93,935
+56,950
| +154% | +$703K | ﹤0.01% | 3441 |
|
|
2023
Q2 | $334K | Sell |
36,985
-3,910
| -10% | -$35.3K | ﹤0.01% | 4184 |
|
|
2023
Q1 | $142K | Buy |
40,895
+8,902
| +28% | +$30.9K | ﹤0.01% | 4613 |
|
|
2022
Q4 | $78.4K | Sell |
31,993
-157,016
| -83% | -$385K | ﹤0.01% | 4723 |
|
|
2022
Q3 | $522K | Sell |
189,009
-16,288
| -8% | -$45K | ﹤0.01% | 4213 |
|
|
2022
Q2 | $835K | Sell |
205,297
-240,651
| -54% | -$979K | ﹤0.01% | 4075 |
|
|
2022
Q1 | $1.9M | Buy |
445,948
+228,348
| +105% | +$972K | ﹤0.01% | 3633 |
|
|
2021
Q4 | $2.04M | Buy |
217,600
+66,981
| +44% | +$627K | ﹤0.01% | 3483 |
|
|
2021
Q3 | $4.15M | Buy |
150,619
+101,507
| +207% | +$2.8M | ﹤0.01% | 2914 |
|
|
2021
Q2 | $1.37M | Buy |
49,112
+28,011
| +133% | +$784K | ﹤0.01% | 3799 |
|
|
2021
Q1 | $700K | Sell |
21,101
-34,064
| -62% | -$1.13M | ﹤0.01% | 4153 |
|
|
2020
Q4 | $2.65M | Buy |
+55,165
| New | +$2.65M | ﹤0.01% | 2890 |
|